Authors:
Lang, S
Zeidler, R
Pauli, C
Andratschke, M
Wollenberg, B
Citation: S. Lang et al., Targeting head and neck cancer by IL-2-mediated gene therapy: From bench to bedside - A review., LARY RH OTO, 80(4), 2001, pp. 191-195
Authors:
Wieser, R
Schreiner, U
Wollenberg, B
Neubauer, A
Fonatsch, C
Rieder, H
Citation: R. Wieser et al., Masked inv(3)(q21q26) in a patient with minimally differentiated acute myeloid leukemia, HAEMATOLOG, 86(2), 2001, pp. 214-215
Authors:
Restrepo-Schafer, I
Wollenberg, B
Riera-Knorrenschild, J
Gorg, C
Citation: I. Restrepo-schafer et al., Partially reversed intrasplenic venous blood flow detected by color Doppler sonography in two patients with hematologic diseases and splenomegaly, J CLIN ULTR, 29(5), 2001, pp. 294-297
Authors:
Gires, O
Kieu, C
Fix, P
Schmitt, B
Munz, M
Wollenberg, B
Zeidler, R
Citation: O. Gires et al., Tumor necrosis factor alpha negatively regulates the expression of the carcinoma-associated antigen epithelial cell adhesion molecule, CANCER, 92(3), 2001, pp. 620-628
Citation: C. Gorg et al., Reversed portal vein pulsatility on Doppler ultrasound secondary to an iatrogenic mediastinal haematoma, BR J RADIOL, 74(886), 2001, pp. 962-964
Authors:
Zeidler, R
Csanady, M
Gires, O
Lang, S
Schmitt, B
Wollenberg, B
Citation: R. Zeidler et al., Tumor cell-derived prostaglandin E2 inhibits monocyte function by interfering with CCR5 and Mac-1, FASEB J, 14(5), 2000, pp. 661-668
Authors:
Zeidler, R
Mysliwietz, J
Csanady, M
Walz, A
Ziegler, I
Schmitt, B
Wollenberg, B
Lindhofer, H
Citation: R. Zeidler et al., The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cells, BR J CANC, 83(2), 2000, pp. 261-266
Authors:
Wollenberg, B",Kastenbauer,"Mundl, H
Schaumberg, J
Mayer, A
Andratschke, M
Lang, S
Pauli, C
Zeidler, R
Ihrler, S",Lohrs,"Naujoks, K
Citation: H. Wollenberg, B",kastenbauer,"mundl et al., Gene therapy - Phase I trial for primary untreated head and neck squamous cell cancer (HNSCC) UICC stage II-IV with a single intratumoral injection of hIL-2 plasmids formulated in DOTMA/Chol, HUM GENE TH, 10(1), 1999, pp. 141-147
Citation: E. Kastenbauer et B. Wollenberg, Searching for new treatment strategies in carcinomas of the head and neck, LARY RH OTO, 78(1), 1999, pp. 31-35
Authors:
Wollenberg, B
Lang, S
Friess, T
Naujoks, K
Mayer, A
Kastenbauer, E
Zeidler, R
Citation: B. Wollenberg et al., Induction of an antitumor immune response in a mouse model after vaccination with B7.1 expressing tumor cells., LARY RH OTO, 78(1), 1999, pp. 36-40
Authors:
Lang, S
Whiteside, TL
Lebeau, A
Zeidler, R
Mack, B
Wollenberg, B
Citation: S. Lang et al., Impairment of T-cell activation in head and neck cancer in situ and in vitro - Strategies for an immune restoration, ARCH OTOLAR, 125(1), 1999, pp. 82-88
Authors:
Chaubal, S
Wollenberg, B
Kastenbauer, E
Zeidler, R
Citation: S. Chaubal et al., Ep-CAM - A marker for the detection of disseminated tumor cells in patients suffering from SCCHN, ANTICANC R, 19(3B), 1999, pp. 2237-2242
Authors:
Zeidler, R
Reisbach, G
Wollenberg, B
Lang, S
Chaubal, S
Schmitt, B
Lindhofer, H
Citation: R. Zeidler et al., Simultaneous activation of T cells and accessory cells by a new class of intact bispecific antibody results in efficient tumor cell killing, J IMMUNOL, 163(3), 1999, pp. 1246-1252
Citation: B. Wollenberg, Immunological approaches to the treatment of squamous cell carcinomas of the head and neck region (HNSCC), LARY RH OTO, 77(11), 1998, pp. 631-634